Alexander C Flint1, S P Cullen, B S Faigeles, V A Rao. 1. Department of Neurocritical Care and Stroke, Regional Neuroscience Program, Kaiser Permanente Northern California, Redwood City, California 94063, USA. alexander.c.flint@kp.org
Abstract
BACKGROUND AND PURPOSE: Endovascular treatments are being increasingly used in acute ischemic stroke, and better tools are needed to determine which patients may benefit most from these techniques. We hypothesized that specific chronic diseases can be used, along with age and stroke severity, to predict endovascular stroke treatment outcomes. MATERIALS AND METHODS: Data from 2 single-arm trials of a thrombectomy device, MERCI and Multi MERCI, were pooled for analysis. A predictive score was developed by using the independent contribution of variables in multivariable analysis. RESULTS: HTN, DM, and AFib were found to predict outcomes. These 3 conditions contribute equally to a CDS that predicts outcomes independent of other predictor variables, including age, stroke severity, and vessel recanalization. A 10-level predictive score, the THRIVE score, which incorporates age, stroke severity, and the CDS, was developed. The THRIVE score strongly predicts outcome and mortality at 90 days. CONCLUSIONS: Specific chronic diseases influence poststroke outcomes among patients undergoing endovascular stroke treatment, independent of other predictors of outcome. The THRIVE score reflects the contributions of chronic disease, age, and stroke severity and strongly predicts endovascular stroke treatment outcomes.
BACKGROUND AND PURPOSE: Endovascular treatments are being increasingly used in acute ischemic stroke, and better tools are needed to determine which patients may benefit most from these techniques. We hypothesized that specific chronic diseases can be used, along with age and stroke severity, to predict endovascular stroke treatment outcomes. MATERIALS AND METHODS: Data from 2 single-arm trials of a thrombectomy device, MERCI and Multi MERCI, were pooled for analysis. A predictive score was developed by using the independent contribution of variables in multivariable analysis. RESULTS: HTN, DM, and AFib were found to predict outcomes. These 3 conditions contribute equally to a CDS that predicts outcomes independent of other predictor variables, including age, stroke severity, and vessel recanalization. A 10-level predictive score, the THRIVE score, which incorporates age, stroke severity, and the CDS, was developed. The THRIVE score strongly predicts outcome and mortality at 90 days. CONCLUSIONS: Specific chronic diseases influence poststroke outcomes among patients undergoing endovascular stroke treatment, independent of other predictors of outcome. The THRIVE score reflects the contributions of chronic disease, age, and stroke severity and strongly predicts endovascular stroke treatment outcomes.
Authors: A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera Journal: JAMA Date: 1999-12-01 Impact factor: 56.272
Authors: Wade S Smith; Gene Sung; Sidney Starkman; Jeffrey L Saver; Chelsea S Kidwell; Y Pierre Gobin; Helmi L Lutsep; Gary M Nesbit; Thomas Grobelny; Marilyn M Rymer; Isaac E Silverman; Randall T Higashida; Ronald F Budzik; Michael P Marks Journal: Stroke Date: 2005-06-16 Impact factor: 7.914
Authors: Hen Hallevi; Andrew D Barreto; David S Liebeskind; Miriam M Morales; Sheryl B Martin-Schild; Anitha T Abraham; Jignesh Gadia; Jeffrey L Saver; James C Grotta; Sean I Savitz Journal: Stroke Date: 2009-04-09 Impact factor: 7.914
Authors: A Bose; H Henkes; K Alfke; W Reith; T E Mayer; A Berlis; V Branca; S Po Sit Journal: AJNR Am J Neuroradiol Date: 2008-05-22 Impact factor: 3.825
Authors: Wade S Smith; Gene Sung; Jeffrey Saver; Ronald Budzik; Gary Duckwiler; David S Liebeskind; Helmi L Lutsep; Marilyn M Rymer; Randall T Higashida; Sidney Starkman; Y Pierre Gobin; Donald Frei; Thomas Grobelny; Frank Hellinger; Dan Huddle; Chelsea Kidwell; Walter Koroshetz; Michael Marks; Gary Nesbit; Isaac E Silverman Journal: Stroke Date: 2008-02-28 Impact factor: 7.914
Authors: Jens Fiehler; Michael Söderman; Francis Turjman; Philip M White; Søren Jacob Bakke; Salvatore Mangiafico; Rüdiger von Kummer; Mario Muto; Christophe Cognard; Jan Gralla Journal: Neuroradiology Date: 2012-09-05 Impact factor: 2.804
Authors: Alexander C Flint; Sean P Cullen; Vivek A Rao; Bonnie S Faigeles; Vitor M Pereira; Elad I Levy; Tudor G Jovin; David S Liebeskind; Raul G Nogueira; Reza Jahan; Jeffrey L Saver Journal: Int J Stroke Date: 2014-05-20 Impact factor: 5.266
Authors: Courtney E Takahashi; Ansgar M Brambrink; Michael F Aziz; Elizabeth Macri; Joshua Raines; Anmol Multani-Kohol; Holly E Hinson; Helmi L Lutsep; Wayne M Clark; Jeremy D Fields Journal: Neurocrit Care Date: 2014-04 Impact factor: 3.210
Authors: Amelia K Boehme; Pawan V Rawal; Michael J Lyerly; Karen C Albright; Reza Bavarsad Shahripour; Paola Palazzo; Niren Kapoor; Mohammad Alvi; J Thomas Houston; Mark R Harrigan; Luis Cava; April Sisson; Anne W Alexandrov; Andrei V Alexandrov Journal: J Stroke Cerebrovasc Dis Date: 2014-08-10 Impact factor: 2.136
Authors: S Prabhakaran; M Soltanolkotabi; A R Honarmand; R A Bernstein; V H Lee; J J Conners; F Dehkordi-Vakil; A Shaibani; M C Hurley; S A Ansari Journal: AJNR Am J Neuroradiol Date: 2014-03-27 Impact factor: 3.825
Authors: Alexander C Flint; Bin Xiang; Rishi Gupta; Raul G Nogueira; Helmi L Lutsep; Tudor G Jovin; Gregory W Albers; David S Liebeskind; Nerses Sanossian; Wade S Smith Journal: Stroke Date: 2013-09-26 Impact factor: 7.914
Authors: Mei-Ling Sharon Tai; Khean Jin Goh; Khairul Azmi Abdul Kadir; Mohd Idzwan Zakaria; Jun Fai Yap; Kay Sin Tan Journal: Singapore Med J Date: 2018-11-29 Impact factor: 1.858
Authors: Vishal N Patel; Rishi Gupta; Christopher M Horn; Tommy T Thomas; Raul G Nogueira Journal: Curr Treat Options Neurol Date: 2013-04 Impact factor: 3.598